Narrative review discusses screening and prevention in rheumatic and musculoskeletal disease populations.
Joint Pain May Signal Hidden Risk in Your Legs
This narrative review examines patients with rheumatic and musculoskeletal diseases (RMDs), including rheumatoid arthritis and systemic lupu…
Inflammation from autoimmune conditions can silently damage blood vessels in your legs.
PPI-refractory GERD prevalence and mechanisms in systemic sclerosis using ambulatory pH-MII, HREM, and scintigraphy
Heartburn Pills Often Fail in Scleroderma—New Study Reveals Why
This retrospective cohort study of 30 adults with systemic sclerosis evaluated PPI-refractory GERD using ambulatory pH-MII, HREM, and gastri…
Standard heartburn pills often fail for scleroderma patients because weak muscle movement in the esophagus and stomach prevents acid from cl…
Inflammatory and metabolic markers differ across systemic sclerosis lung phenotypes in retrospective study
Scleroderma Lung Damage May Leave Hidden Clues in Blood
A retrospective cross-sectional study of 314 SSc inpatients found higher inflammatory markers (ESR, hs-CRP, CRP/albumin ratio, SII) and anti…
Routine blood tests may soon reveal hidden lung damage patterns in scleroderma patients, helping doctors spot dangerous complications before…
Nailfold videocapillaroscopy patterns associate with interstitial lung disease and skin fibrosis in systemic sclerosis patients.
Does the tiny pattern in your nailbeds predict serious lung scarring in scleroderma?
This prospective cross-sectional study evaluated 70 patients with systemic sclerosis to assess associations between nailfold videocapillaros…
Tiny changes under fingernails can warn of serious lung scarring in scleroderma patients, linking nail patterns to disease severity and qual…
Itch prevalence and severity remain stable over time in systemic sclerosis cohort study
For people with scleroderma, how common is itch — and does it ever go away?
An observational cohort study of 2173 people with systemic sclerosis found itch prevalence was 35-37% and mean severity 4.1-4.4 on a 0-10 sc…
For people with scleroderma, a new study shows itch is common and stays steady over time, challenging the idea that it is just an early-phas…